TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Vaccinium Invest AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2024/04 | 2023/04 |
| Turnover |
12,794
|
2,134
|
4,004 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
4,520
|
1,227
|
479 |
| EBITDA |
-59
|
333
|
-55 |
| Total assets |
5,329
|
1,215
|
877 |
| Current assets |
3,123
|
1,203
|
864 |
| Current liabilities |
90
|
77
|
0 |
| Equity capital |
5,239
|
1,138
|
877 |
| - share capital |
4
|
4
|
4 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2024/04 | 2023/04 |
| Solvency |
98.3%
|
93.7%
|
100% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
35.3%
|
57.5%
|
12.0% |
| Return on assets (ROA) |
84.8%
|
101.0%
|
54.6% |
| Current ratio |
3470.0%
|
1562.3% | |
| Return on equity (ROE) |
86.3%
|
107.8%
|
54.6% |
| Change turnover |
10,611
|
-1,723
|
4,004 |
| Change turnover % |
486%
|
-45% | |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2024/04 | 2023/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.